Navigation Links
6th ESOU Meeting
Date:12/16/2008

The 6th Meeting of the European Society of Oncological Urology (ESOU) will be held in Istanbul, Turkey, from 16 to 18 January 2009, with organisers presenting the latest updates on treatment strategies to onco-urology specialists.

With the fast-changing developments in onco-urological treatment strategies, the ESOU aims to provide urologists, gynaecologists, oncologists, scientists and researchers the opportunity to explore the various options that will enable cancer specialists to identify optimal treatment approaches.

"The ESOU is and intends to remain - one of the most important platforms of scientific information exchange among experts as well as professionals interested in the field. It will continue to serve as a key opinion leader and promote the dissemination of high-quality uro-oncological scientific information, in order to increase the quality of medical service," said ESOU Chairman Prof. Vincent Ravery (Paris, France).

The most common malignancies such as prostate cancer (PCa), renal cell carcinoma and bladder cancer were the focus of last year's meeting in Berlin. Apart from these conditions, testis cancer will be another highlight of the forthcoming meeting in Istanbul.

Prof. Levent Trkeri (Istanbul, Turkey), ESOU board member and local organiser said: "On Friday, 16 January, an interesting pro-contra debate is organised entitled 'Should hormones (adjuvant/neo-adjuvant) be dedicated to radiotherapy and abandoned in patients to be treated with surgery?' Furthermore, the lecture by Prof. Theo de Reijke of the European Organisation on the Research and Treatment of Cancer-Genitourinary Group (Update on the recent data retrieved from EORTC GU group studies) deserves attention."

The introduction of targeted therapies, which will be discussed during the sessions on renal cell carcinoma, meant a revolution in the field of oncology in general. These therapies appear to evolve into the mainstay of medical treatment of malignancies of the urogenital tract and are likely to convert the disease from a progressive and lethal one into a chronic, controllable process in many cases.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
31-263-890-680
European Association of Urology
Source:Eurekalert

Related biology news :

1. Society for General Microbiology 161st Meeting, University of Edinburgh
2. Planetary geoscience, paleontology, and more at GSA Annual Meeting in Denver next month
3. Colony collapse disorder symposium added to ESA Annual Meeting
4. Meeting real-world climate information needs of business, government
5. Food and environmental sustainability focus of ASA-CSSA-SSSA Annual Meetings
6. NAS Biodiversity and Extinction Meeting Dec. 7-8
7. HGS announces positive Phase 2 LymphoStat-B at ACR meeting
8. New studies on schizophrenia, depression, trauma and autism highlight annual meeting
9. Roger Kornberg to present lecture at the Joint Biophysical Society/IUPAB Meeting
10. Media advisory -- 2008 Ocean Sciences Meeting
11. ASNTR 15th anniversary meeting to be held May 1-3 in Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):
(Date:5/15/2017)... ... May 15, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that it has signed ... diseases, to support preclinical and clinical development of TA-46, a novel protein addressing ...
(Date:5/15/2017)... Calif. (PRWEB) , ... May 15, 2017 , ... ... May 1 brand refresh, the clinical skincare brand has today launched its first-ever ... mantra is now being shared across digital and social media channels, emphasizing Algenist’s ...
(Date:5/12/2017)... , May 12, 2017 GreenMark Biomedical ... present at the 36th annual Michigan Growth Capital Symposium ... a Delaware corporation with facilities ... to investors in attendance, including more than 100 top ... benefits to society through biobased targeting technologies. ...
(Date:5/11/2017)... --  BioLife Solutions , Inc. (NASDAQ: BLFS ), ... cell and tissue hypothermic storage and cryopreservation ... highlights and financial results for the first quarter of 2017. ... new high of $2.4 million in the first quarter of ... 2016. Revenue growth was driven by sales of CryoStor ...
Breaking Biology Technology: